Health-related quality of life, treatment efficacy, and hemodialysis patient outcome

Renal Failure

Volumn 31, Issue 3, 2009, Pages 201-206

  Simic Ogrizovic, Sanja ^a,b   Jemcov, Tamara ^a   Pejanovic, Svetlana ^a   Stosovic, Milan ^a   Radovic, Milan ^a   Djukanovic, Ljubica ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b Department of Nephrology ^*  (Serbia)

Author keywords

Health related quality of life; Hemodialysis adequacy; Hemodialysis patients' outcome

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; FEMALE; GROUPS BY AGE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; THERAPY EFFECT; TREATMENT DURATION; BLOOD; CHRONIC KIDNEY FAILURE; DAILY LIFE ACTIVITY; HEALTH STATUS; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGICAL ASPECT; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEALTH STATUS; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SATISFACTION; PROPORTIONAL HAZARDS MODELS; QUALITY OF LIFE; RENAL DIALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 65549163956     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220802669842     Document Type: Article

References (18)

1. Valderrabano F, Joffre R, Lopez-Gomez M. Quality of life in end-stage renal disease patients. Am J Kidney Dis. 2001; 38:443-464.
2. Molsted S, Prescott L, Heaf J, Eidemak I. Assessment and clinical aspects of health-related quality of life in dialysis patients and patients with chronic kidney disease. Nephron Clin Pract. 2007;106(1):24-33.
3. Bakewell B, Higgins M, Edmund E. Quality of life in peritoneal dialysis patients: Decline over time and association with clinical outcomes. Kidney Int. 2002;61:239-248.
4. Kutner G, Zhang R, Bernhart H, Collins J. Health status and quality of life reported by incident patients after one year on hemodialysis or peritoneal dialysis. Nephrol Dial Transplant. 2005;20:2159-2167.
5. Fukuhara S, Lopez A, Bragg-Gresham L, Kurokawa K, Mapes D, Akizawa T, Bommer J, Canaud J, Port F, Held K, Held J, for the Worldwide DOPPS. Kidney Int. 2003; 64:1903-1910.
6. Vazquez I, Valderrabano F, Fort J, Jofre J, Lopez-Gomez M, Moreno F, Sanz-Guajardo D. Psychosocial factors and health-related quality of life in hemodialysis patients. Qual Life Res. 2005;14:179-190.
7. Mapes D, Lopes A, Satayathum S, McCullough P, Goodkin A, Locatelli F, Fukahara S, Young W, Kurokawa K, Saito A, Bommer J, Wolfe R, Held J, Port F. Health-related quality of life as a predictor of mortality and hospitalization: The Dialysis and Practice Study (DOPPS). Kidney Int. 2003;64:339-349.
8. European best practice guidelines for treatment of anemia in chronic renal failure. Nephrol Dial Transplant. 2002; 17:48-49.
9. Blake P, Daugirdas P. Quantification and prescription general principles. In Jacobs C, Kjellstrand M, Koch M., Winchester F, eds. Replacement of renal function by dialysis. Dordrecht: Kluwer Academic Publishers; 1996:619-656.
10. Hays D, Kallich D, Mapes L, Coons J, Amin N, Carter WB. Kidney Disease Quality of Life - Short Form (KDQOL-SF™), Version 1.3: A manual for use and scoring. Santa Monica, Calif.: RAND; 1995: P-7994.
11. Cronbach L. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297-234.
12. Merkus P, Jager J, Dekker W, De Haan J, Boesschote W, Krediet T. Quality of life over time in dialysis: the Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group. Kidney Int. 1999;56:720-728.
13. Garcia-Mendoza M, Valdés C, Ortega T, Rebollo P, Ortega F. Differences in health-related quality of life between elderly and younger patients on hemodialysis. J Nephrol. 2006;19: 808-818.
14. Vos F, Zilh O, Janekens-Schinkel J, Salden M, Nuyen J, Menno P, Kooistra M, van Hufflen C, Sitskoorn M. Effect of short daily hemodialysis on quality of life, cognitive functioning and the electroencephalogram. Nephrol Dial Transplant. 2006;10:1-7.
15. Canadian Erythropoietin Study Group. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving hemodialysis. Br Med J. 1990;300:573-578.
16. Feldt-Rasmussen B, Lange M, Sulowicz W, Gafter U, Lai N, Wiedemann J, Christiansen S, El Nahas M, for the APCD Study Group. Growth hormone treatment during hemodial-ysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk. Am Soc Nephrol. 2007;18: 2161-2171.
17. Culleton F, Walsh M, Klarenbach W, Mortis G, Scott-Douglas N, Quinn R, Tonelli M, Donnelly S, Friedrich G, Kumar A, Mahallati H, Hemmelgarn R, Manns BJ. Effect of frequent nocturnal hemodialysis vs. conventional hemodial-ysis on left ventricular mass and quality of life: A randomized controlled trial. JAMA. 2007;298:1331-1333.
18. Knight L, Ofsthun N, Teng M, Lazarus M. Curhan C. The association between mental health, physical function, and hemodialysis mortality. Kidney Int. 2003;63:1843-1851.